二甲双胍增强人脂肪源基质细胞促再生功能用于糖尿病创面愈合
本研究探讨二甲双胍能否增强脂肪源间充质基质细胞(ASC)功能以促进糖尿病创面愈合。转录组分析识别了血管生成、炎症、细胞外基质重塑和细胞存活相关通路;二甲双胍浓度依赖性促进ASC增殖、增强成纤维细胞迁移和血管生成因子分泌,并改善ASC在SIS支架上的黏附。但高糖条件部分削弱上述效应,提示代谢应激影响再生反应。
要点
- 二甲双胍浓度依赖性促进ASC增殖并维持长期扩增。
- 二甲双胍增强ASC旁分泌促修复信号和血管生成因子分泌。
- 高糖条件部分削弱二甲双胍对ASC的促再生效应。
核心结论
- 二甲双胍预处理可促进ASC的促再生表型,增强增殖、旁分泌信号、内皮相关反应和支架整合,但高糖条件部分削弱这些效应。
研究设计与样本
- 本研究为体外实验研究,采用人脂肪源间充质基质细胞(ASC),进行转录组分析及功能实验。
主要发现
- 转录组分析识别了血管生成、炎症、细胞外基质重塑和细胞存活相关通路,包括PI3K–AKT、JAK–STAT和AGE–RAGE信号。
- 二甲双胍浓度依赖性增加ASC增殖并促进持续细胞扩增。
- 二甲双胍处理的ASC在共培养系统中增强成纤维细胞迁移。
- 二甲双胍增加血管内皮生长因子(VEGF)和成纤维细胞生长因子(FGF)分泌。
- 二甲双胍增强常糖条件下ASC的CD31表达和管形成能力(尤其联合VEGF),但高糖条件下这些效应减弱;二甲双胍改善ASC在小肠黏膜下层(SIS)支架上的黏附并支持三维生物材料环境中内皮标志物表达。
临床怎么用
- 二甲双胍预处理可能作为增强ASC为基础的治疗策略用于慢性和糖尿病创面愈合。
局限性
- 高糖条件部分 impair 二甲双胍对ASC的促再生效应,提示代谢应激影响再生反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Chronic wounds associated with diabetes remain a major challenge due to impaired angiogenesis, reduced fibroblast activity and dysfunction of regenerative cells. Adipose-derived mesenchymal stromal cells (ASCs) represent a promising therapeutic option; however, their regenerative potential is limited under hyperglycaemic conditions. This study investigated whether metformin could enhance ASC function and improve their therapeutic potential for tissue regeneration. Transcriptomic analysis of wound tissue identified pathways associated with angiogenesis, inflammation, extracellular matrix remodelling and cell survival, including PI3K–AKT, JAK–STAT and AGE–RAGE signalling. Functionally, metformin increased ASC proliferation in a concentration-dependent manner and promoted sustained cell expansion over time. Metformin-treated ASCs also enhanced fibroblast migration in a co-culture system, indicating improved paracrine pro-reparative signalling. Metformin further increased the secretion of angiogenic factors, including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), supporting a pro-angiogenic secretory profile. Metformin enhanced CD31 expression and tube formation capacity of ASCs under normoglycemic conditions, particularly in combination with VEGF; however, these effects were attenuated under high-glucose conditions. Additionally, metformin improved ASC adhesion to small intestinal submucosa (SIS) scaffolds and supported endothelial marker expression in a three-dimensional biomaterial environment. Collectively, these findings demonstrate that metformin promotes a pro-regenerative ASC phenotype characterized by enhanced proliferation, paracrine signalling, endothelial-associated responses and scaffold integration. However, hyperglycaemic conditions partially impair these effects, highlighting the influence of metabolic stress on regenerative responses. Overall, metformin preconditioning represents a promising strategy to enhance ASC-based therapies for chronic and diabetic wound healing.
引用
- Wound Repair and Regeneration:Metformin Enhances the Pro‐Regenerative Function of Human Adipose‐Derived Stromal Cells for Diabetic Wound Healing
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。